NCT05821335

Brief Summary

Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 30, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

Same day

First QC Date

April 7, 2023

Last Update Submit

May 4, 2023

Conditions

Keywords

Scleroderma, SystemicHand therapyTherapy, Computer-Assisted

Outcome Measures

Primary Outcomes (1)

  • modified Hand Mobility in Scleroderma (mHAMIS)

    Hand Mobility in Scleroderma is a hand function test developed for adults who have systemic sclerosis. HAMIS consists of 9 items designed to measure all movements assessed in an ordinary range of motion-measured hand test. Each item is graded on a 0-3 scale, where 0 corresponds to normal function and 3 denotes that the individual is unable to perform the item. Each hand is assessed separately. The total score of HAMIS for each hand is 370 Sandqvist and Eklund Vol. 13, No. 6, December 2000 27, which represents a high degree of dysfunction.

    change from baseline at 5 weeks

Secondary Outcomes (4)

  • Finger Joint Range of Motion

    change from baseline at 5 weeks

  • Grip Strength

    change from baseline at 5 weeks

  • Skin Hardness

    change from baseline at 5 weeks

  • Purdue Pegboard Test

    change from baseline at 5 weeks

Study Arms (2)

Leap motion assisted rehabilitation

EXPERIMENTAL

Individuals who will participate in the study will be treated 2 days a week for 5 weeks with Leap Motion sensor-supported games aimed at increasing patient-specific wrist flexion, wrist extension, ulnar and radial deviation of the wrist, flexion, extension and abduction of the fingers. Each training period will last 30 minutes.

Other: Leap motion assisted rehabilitation

Traditional program

EXPERIMENTAL

They will be included in traditional rehabilitation training consisting of stretching exercises, strengthening exercises and functional exercises including activities of daily living for 2 days a week for 5 weeks.

Other: Traditional program

Interventions

Hand Therapy via leap motion sensor

Leap motion assisted rehabilitation

Hand Therapy by physiotherapist via traditional methods

Traditional program

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having the ability to adapt to exercises
  • Not having any diagnosed cardiac or orthopedic disease that may prevent the application of assessment methods

You may not qualify if:

  • Having a diagnosis of juvenile-onset SSc
  • Having a history of neurological disease or trauma that will affect hand functions
  • Receiving another treatment, such as intra-articular injection, surgery, that may affect hand rehabilitation in the last 6 months
  • Having systemic involvement that may affect the treatment process or activities of daily living

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Tarakci E, Arman N, Tarakci D, Kasapcopur O. Leap Motion Controller-based training for upper extremity rehabilitation in children and adolescents with physical disabilities: A randomized controlled trial. J Hand Ther. 2020 Apr-Jun;33(2):220-228.e1. doi: 10.1016/j.jht.2019.03.012. Epub 2019 Apr 19.

    PMID: 31010703BACKGROUND
  • Murphy SL, Poole JL, Chen YT, Lescoat A, Khanna D. Rehabilitation Interventions in Systemic Sclerosis: A Systematic Review and Future Directions. Arthritis Care Res (Hoboken). 2022 Jan;74(1):59-69. doi: 10.1002/acr.24737. Epub 2021 Dec 22.

    PMID: 34165263BACKGROUND

MeSH Terms

Conditions

Scleroderma, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • TUGBA CIVI KARAASLAN, PhD

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

TUGBA CIVI KARAASLAN, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessment and treatment will be done by different investigators.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

April 7, 2023

First Posted

April 20, 2023

Study Start

May 30, 2023

Primary Completion

May 30, 2023

Study Completion

May 30, 2024

Last Updated

May 6, 2023

Record last verified: 2023-05